Ethiopian New Orthodox Mezmur 2019

Diabetes is a global epidemic. More than 346 million people worldwide have the disease (WHO, 2011). Factors linked to this epidemic include urbanization, aging, physical inactivity, unhealthy diet, and obesity. At least 65% of people with diabetes mellitus die from some form of heart or blood vessel disease (AHA, 2008). Diabetes is a major contributor toward the development of CHD and stroke. Also, diabetes is among the leading causes of kidney failure; 10% to 20% of people with diabetes die of kidney failure (WHO, 2008). Prediabetes, in addition to being a positive risk factor for CVD, is a medical condition identified by fasting blood glucose or glycated hemoglobin (HbA1c) levels that are above normal values but lower than the threshold for a diagnosis of diabetes (CDC, 2011). HbA1c is an indicator of the average blood glucose over the past 2 to 3 months. Fortunately, prediabetes appears to respond favorably to weight loss and increases in physical activity. Type 1, formerly referred to as insulin-dependent diabetes mellitus (IDDM), usually occurs before age 30 but can develop at any age. Type 2, previously known as non-insulin-dependent diabetes mellitus (NIDDM), is more common; 90% of individuals diagnosed with diabetes mellitus worldwide have type 2 diabetes (WHO, 2011). Age, gender, family history, calorie intake, physical inactivity are risk factors for developing diabetes. Type 1 diabetes may be caused by autoimmune, genetic, or environmental factors, but the specific cause is unknown. Unfortunately, there is no known way to prevent type 1 diabetes (CDC, 2011). Healthy nutrition and increased physical activity, however, can reduce the risk of type 2 diabetes by as much as 67% in high-risk individuals (Sanz, Gautier, and Hanaire 2010). Nearly 90% of cases of type 2 diabetes worldwide may be related to obesity (Wagner and Brath 2012). The effect of exercise alone as an intervention for people with type 2 diabetes is not well researched. However, exercise (30–120 min, 3 days/wk for 8 wk) produced clinically significant improvements in HbA1c and reduced visceral and subcutaneous adipose tissue stores in people with type 2 diabetes. Additionally, no adverse effects or diabetic complications resulting from 
Orthodox Mezmur
Be the first to comment